MedPath

Evaluation of the effect of oral curcumin on liver enzymes and liver T2*MRI

Phase 3
Recruiting
Conditions
Thalassemia.
Thalassemia
Registration Number
IRCT20201107049296N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Patients with major and intermediate thalassemia

Exclusion Criteria

Parental dissatisfaction
Renal failure
Hepatitis B
Hepatitis C
AIDS

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath